The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1231-2016·Announced 2016-07-20

Medaus Recalls Niacinamide Vials Due to Sterility Concerns

Medaus, Inc. is recalling specific lots of Niacinamide 100 mg/mL vials because the company cannot guarantee the product's sterility.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric for significant injury or property-damage reports or high-risk scenarios.

Plain-English summary

Medaus, Inc. is recalling specific lots of Niacinamide 100 mg/mL (PF) vials in 1 mL, 5 mL, and 10 mL sizes. The recall is being conducted because the company lacks assurance of the sterility of the affected products.

The affected products were distributed nationwide in the United States, as well as in Japan and New Zealand. The recall covers specific lot numbers with expiration dates ranging from May 2016 to September 2016.

Consumers and healthcare providers should stop using the affected vials and contact Medaus, Inc. for further instructions or a return.

The recalled product

Product
NIACINAMIDE 100 MG/ML (PF), In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY
Manufacturer
Medaus, Inc.
Category
Drug — Injectable
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (14)

  • a) Lot #: 160204-29
  • BUD: 08/02/16. b) Lot #: 151123-73
  • BUD: 05/21/16
  • Lot #: 151124-42
  • BUD: 05/22/16
  • Lot #: 151201-20
  • BUD: 05/29/16
  • Lot #: 151215-10
  • BUD: 06/12/16
  • Lot #: 160229-46
  • BUD: 07/17/16
  • Lot #: 160202-33
  • BUD: 07/31/16. c) Lot #: 160315-9
  • BUD: 09/11/16.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 88 recalled by Medaus, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 88 products in this recall →

Related recalls

Same manufacturer · Medaus, Inc.

See all →

Same hazard · sterility

See all →

Similar recalls